Forensic Analysis · Computer Hardware · as of Nov 9, 2026
Omnicell, Inc. (OMCL)
A forensic read on Omnicell, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
C · Mixed — selective
Forensic grade
Safe
Financial health
3.1
Distress distance
Clean
Earnings quality
2
Forensic signals
0.2%
ROE
6.5%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Omnicell, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 3.1, placing it in the Safe zone. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
0.3%
FY2025
Return on invested capital.Return on invested capital is 0.3% in the latest fiscal year and rising across FY2023–FY2025 from -2.0%. After-tax operating profit was ($28M) in FY2023 and $3M in FY2025, with operating income at -3.0% of revenue in FY2023, 0.0% in FY2024 and 0.4% in FY2025. The capital base behind it came down -12% across FY2023–FY2025, from $1.4B to $1.2B, so this return is struck on a smaller base than it started on. FY2023's operating profit carried a $16M restructuring charge that took about 0.9 points off that year's return, and FY2025's carried a $7M restructuring charge that took about 0.3 points off the latest; so, net of each other, the two charges add about 0.6 points to the +2.3-point change across FY2023–FY2025.
+16.9%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +16.9% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by payables paid down 15% against +6% in cost of sales and inventory up +14% against +6% in cost of sales. A cash-flow measure on the same base disagrees: reported earnings ran behind operating cash by 13% of net operating assets, against an accruals ratio of 16.9%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average. Read them as two results, not one.Accruals ratio: the year-over-year change in net operating assets, relative to their own average.NOA (net operating assets): the money tied up in running the business, operating assets minus operating liabilities.
Key fundamentals
Latest Revenue$1.18B
Revenue Growth YoY+6.5%
Revenue CAGR (2yr)+1.6%
Net Margin0.2%
Free Cash Flow$86.9M
Return on Equity0.2%
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Omnicell, Inc.'s actual 10-K/10-Q/8-K filings?